02/14/2025
8:00 AM | RTW INVESTMENTS, LP (Filed by)
Taysha Gene Therapies (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
5:05 PM | Octagon Capital Advisors LP (Filed by)
Taysha Gene Therapies (Subject)
| Form SCHEDULE 13G | |
02/05/2025
9:43 AM | MORGAN STANLEY (Filed by)
Taysha Gene Therapies (Subject)
| Form SCHEDULE 13G | |
01/07/2025
3:34 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/03/2025
4:38 PM | Nolan Sean P. (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:31 PM | Alam Kamran (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
4:36 PM | Nagendran Sukumar (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2024
11:15 PM | Taysha Gene Therapies (Filer)
| Form EFFECT | |
11/14/2024
4:51 PM | Taysha Gene Therapies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
11/14/2024
8:40 AM | Avoro Capital Advisors LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
Get the Latest News and Ratings for TSHA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Taysha Gene Therapies and its competitors with MarketBeat's FREE daily newsletter. |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Taysha Gene Therapies (Subject)
| Form SC 13G | |
08/12/2024
7:32 AM | Taysha Gene Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:05 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
4:49 PM | Porter Fred (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
4:50 PM | McAuliffe Sean (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
4:51 PM | McGinnis Emily (Reporting)
Taysha Gene Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
7:00 AM | Manning Paul B (Reporting)
Taysha Gene Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
4:12 PM | Taysha Gene Therapies (Filer)
| Form 424B5 | |
06/26/2024
4:14 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
5:14 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
5:07 AM | Taysha Gene Therapies (Filer)
| Form 424B5 | |
06/18/2024
6:45 AM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:18 PM | Taysha Gene Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:19 PM | Taysha Gene Therapies (Filer)
| Form ARS | |
04/18/2024
3:21 PM | Taysha Gene Therapies (Filer)
| Form DEFA14A | |
03/19/2024
3:55 PM | Taysha Gene Therapies (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
